TuHURA Biosciences, Inc./NV (HURA) stock
HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.25−0.11 (-8.09%)
Close on Nov 20, 2026Market cap $79.66MP/E –Yield –
TuHURA Biosciences pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
TuHURA Biosciences's pe ratio was 0.3× on Jul 31, 2019, against 0.8× a year earlier. Over the last 3 years it ranged from 0.2× to 14.1×, with a median of 1.2×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2019 | Jul 31, 2019 | 0.3× | −0.4 |
| 2018 | Dec 31, 2018 | 0.7× | −0.2 |
| 2017 | Dec 29, 2017 | 0.9× | −2.6 |
| 2016 | Dec 30, 2016 | 3.5× | – |
See a number that looks wrong?